Urology News and Research

Latest Urology News and Research

Good Samaritan Hospital receives $417,560 grant to implement telemedicine program

The U.S. Department of Agriculture (USDA) Rural Development awards Good Samaritan Hospital, a prominent downtown Los Angeles hospital, a $417,560 grant to implement a telemedicine program that will connect members of the medical staff at Good Samaritan Hospital with public health and primary care providers and their patients at six Public Health sites on the island of Guam.

27 Nov 2014

Minimally invasive surgeries successfully performed at Policlinico Gemelli in Rome with ALF-X system

It's called ALF-X and it's the innovative robotic surgical system being used by gynaecological surgeons at the A. Gemelli University Polyclinic in Rome, which has been in operation in the surgical field for a year in the Department for the Protection of Health of Women, Newborns, Children and Adolescents, directed by professor Giovanni Scambia.

26 Nov 2014

Perc NGage® and Perc NCompass® nitinol stone extractors launched by Cook Medical

Urologists now have new options for stone extraction devices when performing percutaneous nephrolithotomy (PCNL), as Cook Medical is launching the Perc NGage® and Perc NCompass® nitinol stone extractors today. The new products complement the Perc NCircle®, which has been on the market since 2002 and was the first nitinol extraction device for percutaneous procedures. Cook Medical was the first company to incorporate nitinol into its stone extraction devices.

From COOK MEDICAL INC. 26 Nov 2014

Long-term T therapy in hypogonadal men is safe, does not increase PCa risk, study finds

Testosterone (T) therapy is routinely used in men with hypogonadism, a condition in which diminished function of the gonads occurs. Although there is no evidence that T therapy increases the risk of prostate cancer (PCa), there are still concerns and a paucity of long-term data.

25 Nov 2014

Endo announces acquisition of rights to Natesto (testosterone nasal gel)

Endo International plc, announced today the acquisition of rights to Natesto (testosterone nasal gel), the first and only testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism, from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals Corporation.

24 Nov 2014

20th annual edition of NCCN Guidelines for Prostate Cancer published

The National Comprehensive Cancer Network has published the 20th annual edition of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer—one of the eight original NCCN Guidelines published in November 1996.

23 Nov 2014

Auxilium Pharmaceuticals presents STENDRA clinical data for ED treatment at SMSNA Scientific Meeting

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that data were presented regarding the use of STENDRA® (avanafil) tablets for the treatment of erectile dysfunction (ED) at the 20th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America (SMSNA) held in Miami from November 20-23, 2014.

20 Nov 2014

UT Southwestern researchers identify new gene mutations involved in certain kidney cancers

Using next generation gene sequencing techniques, cancer researchers at UT Southwestern Medical Center have identified more than 3,000 new mutations involved in certain kidney cancers, findings that help explain the diversity of cancer behaviors.

17 Nov 2014

Prostate cancer patients with hereditary BRCA mutations respond less well to conventional treatment

Prostate cancer patients carrying inherited mutations in the BRCA genes respond less well to conventional treatment, including surgery and/or radiotherapy - and they also have a lower survival rate than those who are non-carriers of these genetic mutations. Data from the study, which has been published in the journal European Urology, points to the need for new clinical trials aimed at targeting these mutations in order to tailor treatment for these patients.

17 Nov 2014

Exposure to tobacco smoke, roadway air pollution can contribute to obesity

New research from Keck Medicine of the University of Southern California (USC) bolsters evidence that exposure to tobacco smoke and near-roadway air pollution contributes to the development of obesity.

14 Nov 2014

UT Arlington professor uses tissue-engineered artificial lymph nodes to draw prostate cancer cells

A UT Arlington bioengineering professor is using tissue-engineered artificial lymph nodes to attract prostate cancer cells to better target and eradicate the disease.

5 Nov 2014

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

Dana-Farber Cancer Institute (Dana-Farber) and Astellas Pharma Inc. today announced a three-year collaboration to research and develop small molecule inhibitors of oncogenic K-Ras for the treatment of cancer, including lung cancer.

4 Nov 2014

Men with BPH need to discuss 'male orgasmic dysfunction' with doctors prior to any treatment

NeoTract, Inc., today welcomes the publication of a paper in the British Journal of Urology International which calls for men suffering from enlarged prostate to discuss with their doctors the likely impact of treatment options on their sexual function. Most procedures and many medications can cause sexual dysfunction. Clinical studies show that treatment with the UroLift system has not been associated with any new onset of sustained ejaculatory or erectile dysfunction.

31 Oct 2014

KU researchers find potential therapeutic target for triple-negative breast cancer

A team at the University of Kansas School of Medicine has identified a potential target for treating breast cancer, including a particularly deadly form of the disease.

30 Oct 2014

Study: Certain prostate cancer medications linked to cardiac death risk

A new study has found that certain prostate cancer medications are linked with an increased risk of dying from heart-related causes in men with congestive heart failure or prior heart attacks. Published in BJU International, the findings will help doctors and patients weigh the benefits and risks of the drugs.

30 Oct 2014

UW-Madison receives $8.3 million NIH grant to create new urological research center

The University of Wisconsin-Madison has been awarded an $8.3 million grant from the National Institutes of Health to create a research center focused on urological health.

29 Oct 2014

Robotically assisted CABG surgery reduces complications, cuts recovery times

Robotically assisted coronary artery bypass grafting (CABG) surgery is a rapidly evolving technology that shortens hospital stays and reduces the need for blood products, while decreasing recovery times, making the procedure safer and less risky, says a study presented at the Canadian Cardiovascular Congress.

29 Oct 2014

Game theory and the cancer ecosystem: an interview with Professor Pienta, Johns Hopkins

The classic description of game theory was described by the prisoner's dilemma, which is a situation in which two players have two options where the outcome depends on the simultaneous choice made by the other.

29 Oct 2014

Myriad's Prolaris test included in NCCN Guidelines for men with localized prostate cancer

Myriad Genetics, Inc. today announced that its Prolaris test has been included in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) for all men with localized prostate cancer, regardless of their risk category.

28 Oct 2014

UAB offers MRI-US image fusion technique for prostate cancer detection

The latest advancement in prostate cancer detection is magnetic resonance imaging and ultrasound fusion-guided biopsy, which offers benefits for both patient and physician.

25 Oct 2014

Urology News and Research

Latest Urology News and Research

Good Samaritan Hospital receives $417,560 grant to implement telemedicine program

Minimally invasive surgeries successfully performed at Policlinico Gemelli in Rome with ALF-X system

Perc NGage® and Perc NCompass® nitinol stone extractors launched by Cook Medical

Long-term T therapy in hypogonadal men is safe, does not increase PCa risk, study finds

Endo announces acquisition of rights to Natesto (testosterone nasal gel)

20th annual edition of NCCN Guidelines for Prostate Cancer published

Auxilium Pharmaceuticals presents STENDRA clinical data for ED treatment at SMSNA Scientific Meeting

UT Southwestern researchers identify new gene mutations involved in certain kidney cancers

Prostate cancer patients with hereditary BRCA mutations respond less well to conventional treatment

Exposure to tobacco smoke, roadway air pollution can contribute to obesity

UT Arlington professor uses tissue-engineered artificial lymph nodes to draw prostate cancer cells

Astellas, Dana-Farber to develop K-Ras inhibitors for treatment of lung, pancreatic cancers

Men with BPH need to discuss 'male orgasmic dysfunction' with doctors prior to any treatment

KU researchers find potential therapeutic target for triple-negative breast cancer

Study: Certain prostate cancer medications linked to cardiac death risk

UW-Madison receives $8.3 million NIH grant to create new urological research center

Robotically assisted CABG surgery reduces complications, cuts recovery times

Game theory and the cancer ecosystem: an interview with Professor Pienta, Johns Hopkins

Myriad's Prolaris test included in NCCN Guidelines for men with localized prostate cancer

UAB offers MRI-US image fusion technique for prostate cancer detection

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Urology News and Research

Latest Urology News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in